IDiyas

For the Inventor, By the Inventor

Doylestown, PA, United States of America

Laura A Vitale

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 134(Granted Patents)


Location History:

  • Doyelstown, PA (US) (2013)
  • Doylestown, PA (US) (2008 - 2022)

Company Filing History:

goldMedal13 out of 45 
 
Celldex Therapeutics Limited
 patents
silverMedal2 out of 152 
 
Medarex Inc.
 patents

Years Active: 2008-2025

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 12297266 - Agonistic antibodies that bind human CD40 and uses thereof (2025-05-13),
2. 11459393 - Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs (2022-10-04),
3. 11332537 - Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs (2022-05-17),
4. 11180566 - Antibodies that bind human CD27 and uses thereof (2021-11-23),
5. 10941201 - Methods of inducing or enhancing an immune response comprising administering agonistic anti-CD40 antibodies (2021-03-09),
6. 10865244 - Nucleic acids encoding agonistic antibodies that bind CD40 (2020-12-15),
7. 10633444 - Agonistic antibodies that bind CD40 (2020-04-28),
8. 9624300 - Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) (2017-04-18),
9. 9169325 - Antibodies that bind human CD27 and uses thereof (2015-10-27),
10. 8586720 - Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) (2013-11-19),
11. 8404820 - [object Object] (2013-03-26),
12. 8362214 - Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) (2013-01-29),
13. 8318165 - Antibodies against human melanoma-associated chondroitin sulphate proteoglycan (MCSP) (2012-11-27),
14. 8236318 - Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) (2012-08-07),
15. 7456264 - [object Object] (2008-11-25),

Title: Laura A. Vitale: Innovator in Immunotherapy

Introduction

Laura A. Vitale is a prominent inventor based in Doylestown, PA (US), known for her significant contributions to the field of immunotherapy. With a remarkable portfolio of 15 patents, she has made strides in developing therapeutic and diagnostic methods that harness the power of antibodies.

Latest Patents

Among her latest patents is the development of agonistic antibodies that bind to human CD40. This patent discloses isolated monoclonal agonistic antibodies and related antibody-based compositions, along with therapeutic and diagnostic methods for their use. Another notable patent involves anti-CD27 and anti-PD-L1 antibodies and bispecific constructs. This innovation provides methods for stimulating T cell activity and enhancing immune responses, offering potential treatments for various diseases.

Career Highlights

Laura has worked with leading companies in the biotechnology sector, including Celldex Therapeutics Limited and Medarex Inc. Her work in these organizations has been pivotal in advancing research and development in immunotherapy.

Collaborations

Throughout her career, Laura has collaborated with esteemed colleagues such as Tibor P. Keler and Lizhen He, contributing to the advancement of innovative therapeutic solutions.

Conclusion

Laura A. Vitale's work exemplifies the impact of innovation in the field of immunotherapy. Her patents and collaborations continue to pave the way for new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…